Effects of Combination of Proliferative Agents and Erythropoietin on Left Ventricular Remodeling Post-Myocardial Infarction.
- Resource Type
- Article
- Authors
- Kanashiro-Takeuchi, Rosemeire M.; Takeuchi, Lauro M.; Hatzistergos, Konstantinos; Quevedo, Henry; Selem, Sarah M.; Treuer, Adriana V.; Premer, Courtney; Balkan, Wayne; Margitich, Irene; Yun Song; Qinghua Hu; Hare, Joshua M.
- Source
- CTS: Clinical & Translational Science. Jun2011, Vol. 4 Issue 3, p168-174. 7p. 2 Charts, 5 Graphs.
- Subject
- *ERYTHROPOIETIN
*HEMATOPOIETIC growth factors
*PERFORMANCE-enhancing drugs
*ENDOTHELIUM
*NEOVASCULARIZATION
*GONADOTROPIN
- Language
- ISSN
- 1752-8054
Erythropoietin (EPO) has the potential to improve ischemic tissue by mobilizing endothelial progenitor cells and enhancing neovascularization. We hypothesized that combining EPO with human chorionic gonadotrophin (hCG) would improve post-myocardial infarction (MI) effects synergistically. [ABSTRACT FROM AUTHOR]